C.T. Fitzpatrick
Vulcan Value Partners
Vulcan Value Partners Medpace Holdings Inc stake
total: 273
Vulcan Value Partners MEDP trades
- Total transactions:
- 21
- New positions:
- 1
- Added:
- 7
- Reduced:
- 13
- Held since:
- 2021 Q2
- Held for:
- 21 quarters
- Latest activity:
- 2026 Q2
According to 2026 Q2 report, Vulcan Value Partners holds 141,743 Medpace Holdings Inc (MEDP) shares with a market value of roughly $75.07M accounting for 2.28% of the overall portfolio. To date, the estimated cost basis is nearly $249.16 for "buy" trades and estimated average "sell" price is $324.7. Vulcan Value Partners first purchased MEDP in 2021 Q2, initially acquiring 225,176 shares. Since the initial investment in Medpace Holdings Inc (MEDP), Vulcan Value Partners has made 20 more transactions.
When did Vulcan Value Partners buy Medpace Holdings Inc (MEDP)?
Vulcan Value Partners first invested in Medpace Holdings Inc (MEDP) in 2021 Q2 at the reported quarter-end price of $176.63 per share.
What's the cost basis of Vulcan Value Partners's MEDP stake?
The estimated cost basis for Medpace Holdings Inc (MEDP) stake is around $249.16 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $249.16
- Weighted AVG sell price:
- $324.70
Vulcan Value Partners's historical trades in Medpace Holdings Inc
21 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2026 Q2
|
2.28%
|
141,743
|
$529.59
|
$75,065,675
|
-30.20% (-61,325)
|
-0.86%
|
|
2026 Q1
|
2.58%
|
203,068
|
$480.19
|
$97,511,223
|
+329.26% (+155,762)
|
+1.98%
|
|
2025 Q4
|
0.48%
|
47,306
|
$561.87
|
$26,580,000
|
-76.37% (-152,866)
|
-1.56%
|
|
2025 Q3
|
1.87%
|
200,172
|
$515.76
|
$103,241,211
|
-30.37% (-87,287)
|
-0.79%
|
|
2025 Q2
|
1.71%
|
287,459
|
$336.94
|
$96,855,802
|
-11.80% (-38,457)
|
-0.24%
|
|
2025 Q1
|
1.86%
|
325,916
|
$304.25
|
$99,158,947
|
+221.61% (+224,578)
|
+1.28%
|
|
2024 Q4
|
0.56%
|
101,338
|
$332.23
|
$33,667,524
|
+119.82% (+55,237)
|
+0.31%
|
|
2024 Q3
|
0.26%
|
46,101
|
$333.80
|
$15,388,514
|
+19.43% (+7,501)
|
+0.04%
|
|
2024 Q2
|
0.24%
|
38,600
|
$411.84
|
$15,897,000
|
-49.55% (-37,916)
|
-0.23%
|
|
2024 Q1
|
0.45%
|
76,516
|
$404.15
|
$30,924,000
|
-25.18% (-25,744)
|
-0.15%
|
|
2023 Q4
|
0.46%
|
$306.53
|
-27.02% (-37,859)
|
|||
|
2023 Q3
|
0.52%
|
$242.13
|
-27.02% (-51,889)
|
|||
|
2023 Q2
|
0.58%
|
$240.17
|
-12.95% (-28,563)
|
|||
|
2023 Q1
|
0.52%
|
$188.05
|
+43.84% (+67,229)
|
|||
|
2022 Q4
|
0.44%
|
$212.41
|
-61.78% (-247,861)
|
|||
|
2022 Q3
|
0.74%
|
$157.17
|
-3.51% (-14,605)
|
|||
|
2022 Q2
|
0.61%
|
$149.67
|
-25.97% (-145,835)
|
|||
|
2022 Q1
|
0.56%
|
$163.59
|
+141.44% (+329,023)
|
|||
|
2021 Q4
|
0.26%
|
$217.64
|
-24.60% (-75,884)
|
|||
|
2021 Q3
|
0.31%
|
$189.28
|
+37.01% (+83,328)
|
|||
|
2021 Q2
|
0.22%
|
$176.63
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.